Tag: phase III trials
Emmes partners with ILiAD Biotechnologies for global Phase III trials of...
The collaboration aims to leverage Emmes Group's clinical trial expertise and advanced technological capabilities to accelerate the development of ILiAD's promising pertussis vaccine
COVAXIN for children: Study demonstrates robust safety & immunogenicity in 2-18...
Whole-Virion inactivated SARS-CoV-2 Vaccine (BBV152) has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults......................
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b...
Promising interim results from Phase III clinical trials with Pegylated Interferon alpha-2b in COVID-19 show higher clinical improvement.........................